Research

3d rendering white blood cells with red blood cells
October 8, 2019

A new regulator of B cell development

New findings establish a role for the pro-inflammatory molecule IL-33 in the early development of antibody-producing B cells.

By Leigh MacMillan
October 7, 2019

Biomedical Science Advisory Board member Kaelin wins Nobel Prize

William Kaelin Jr., MD, a member of the Vanderbilt University Medical Center Biomedical Science Advisory Board, has been awarded the 2019 Nobel Prize in Physiology or Medicine.

By Bill Snyder
October 7, 2019

AI maps routes to heart disease

Machine learning on unlabeled electronic health record data has shed light on the emergence of cardiovascular disease.

By Paul Govern
October 3, 2019

Study: personalized decision support affects intensive care

For patients in pediatric intensive care who are at high risk for acute kidney injury (AKI), giving clinicians automated decision support during the electronic order entry process increased the rate of blood testing for AKI by 9%.

By Paul Govern
October 3, 2019

Team discovers one more piece to the autism puzzle

Vanderbilt investigators have linked genetic mutations in a single receptor to epilepsy, autism and intellectual disability.

By Bill Snyder
October 3, 2019

A step toward gastric cancer

New research findings provide insight into the detrimental events that develop in response to H. pylori infection.

By Sanjay Mishra
October 3, 2019

A catalog of DNA replication proteins

Vanderbilt scientists have identified 593 proteins that are enriched at sites of DNA duplication and chromatin packaging of newly synthesized DNA.
By Leigh MacMillan
October 3, 2019

Diabetes drug study explores cardiovascular risks for patients with kidney disease

An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease.
By Paul Govern
October 2, 2019

Research team sorts out drug screen false positive results

Vanderbilt investigators have identified 13 previously unknown drug compounds that cause false positive screenings for amphetamines, buprenorphine (an opioid), cannabinoids and methadone.
By Paul Govern
October 1, 2019

Pua lands NIH Director’s New Innovator Award

Heather Pua, MD, PhD, one of 60 investigators to receive the 2019 NIH Director’s New Innovator Award, will explore a novel type of cell signaling by RNAs in allergic airway inflammation.
By Leigh MacMillan
September 25, 2019

Study shines light on architecture of kidney disease

A study of 280,000 U.S. veterans, including 56,000 African Americans, has identified in greater detail than ever before the genetic architecture of kidney function and chronic kidney disease (CKD), according to researchers at Vanderbilt University Medical Center and their colleagues.
By Bill Snyder
September 25, 2019

Study identifies targeted therapy’s cardiac risks

After a recent study showed that chronic lymphocytic leukemia patients who received ibrutinib as a frontline treatment had a 7% death rate, a new study offers a clearer picture on the reasons for the deaths.
By Tom Wilemon
September 24, 2019

Nobel laureate Südhof set for Oct. 3 Discovery Lecture

Nobel laureate Thomas Südhof, MD, whose studies of synaptic formation and transmission are advancing understanding of brain disorders including autism, Alzheimer’s disease and schizophrenia, will deliver the next Flexner Discovery Lecture on Thursday, Oct. 3.
By Bill Snyder
1 … 77 78 79 80 81 … 126